California residents 65 and older now qualify for COVID-19 vaccinations. Questions about the mRNA Covid-19 vaccines still remain. Vaccine expert Dr. David Lo, a distinguished professor of biomedical sciences and senior associate dean for research in the School of Medicine at the University of California, Riverside, answers several questions in...
The news arrived Monday that the world has been awaiting since spring: a vaccine has been developed that shows a high degree of efficacy in late-stage trials: 90%. That puts it in the company of effective vaccines such as for measles, and well beyond what the medical community hoped for...
UC Riverside-led study shows how variations in SARS-CoV-2 host gene expression can be linked to variations in COVID-19 susceptibility and symptom severity
The UC Riverside School of Medicine's Department of Psychiatry and Neuroscience will launch a unique, first-in-the-nation sports psychiatry fellowship program. Developed in partnership with UC Riverside Intercollegiate Athletics and UCR Health, this non-ACGME program will begin accepting applications in 2021 and will start in 2022. While there are other schools...
A research team led by scientists at the University of California, Riverside, has outlined how the Zika virus, which constituted an epidemic threat in 2016, suppresses the immune system of its host. The Zika virus, or ZIKV, spreads through mosquito bites and sexual intercourse. Currently, no approved vaccine or antivirals...